Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina

Mise à jour : Il y a 4 ans
Référence : NCT01659580

Femme et Homme

Extrait

This phase III study is designed as a double blind, randomized, multi-nation, multi-center, placebo controlled clinical research, which aims to evaluate the safety and efficacy of Dantonic® (T89) in patients with chronic stable angina pectoris.


Critère d'inclusion

  • Angina pectoris


Liens